Table 4 Current and past medications
Total (n = 101) | ERA (n = 41) | P value | |
|---|---|---|---|
Past treatment, n (%) | 60 (59) | 29 (71) | |
cDMARDs | 60 (59) | 29 (71) | 0.206 |
Anti-TNF | 21 (21) | 12 (29) | 0.278 |
Anti-IL6 | 2 (2) | 0 (0) | 1.0 |
Anti-IL1 | 1 (1) | 0 (0) | 1.0 |
JAKi | 2 (2) | 0 (0) | 1.0 |
Current follow-up, n (%) | 71 (70) | 31 (76) | |
Active treatment, n (%) | 34 (48) | 14 (45) | 0.8 |
cDMARDs | 23 (32) | 7 (23) | 0.132 |
anti-TNF | 14 (20) | 8 (26) | 0.762 |